Wpg Advisers, LLC Ptc Therapeutics, Inc. Transaction History
Wpg Advisers, LLC
- $129 Billion
- Q3 2025
A detailed history of Wpg Advisers, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wpg Advisers, LLC holds 16 shares of PTCT stock, worth $1,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$1,092% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
313Shares Held
79.6MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$604 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$531 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$529 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$323 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$321 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.89B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...